Predictable order of events, moving forward. BTW - This happens in mining all the time... property has decent drilling results but costs to mine has never been feasible....
Biopharma is very similar…. rat studies, and small cohort clinical trials are like drilling results.... ultimately there’s no viable profitable business model.... but, management can mine the company for salaries and bonuses...shareholders are the pawns.
Like mining these are the usual order of events;
1 - Restructure with reverse split and wipe out all exiting retail investors… Insiders orchestrate and get new free shares.
2- Name and ticker symbol change to wipe out old charts and past history…prepare the company for the new set of suckers.
3- Do a financing, - Ideally the new company will have 30 to 50 Million shares outstanding, and one years cash in the bank.
4. At some point in the restructure there will be a mass lay-off of employees…maybe sell some assets…. at lot of crying then…. but there will be a bounce upward in share price, and that’s when the short term restructuring vultures get out and let the new pawns move in.
5. Then they start the same game all over again with the new pawns.
Most PLI shareholders will move on, but there’s always a few that stay to get sucked in a second time….. Whom will that be???